C Diff Foundation's 4th Annual C. diff. Awareness Global Campaign Begins November 1, 2016

News provided by

Oct 20, 2016, 05:43 ET

NEW PORT RICHEY, Fla., Oct. 20, 2016 /PRNewswire/ -- C Diff Foundation® a leading non-profit patient advocacy organization, Global healthcare information system, today announced the scheduled events and launching of the 4th annual November C. diff. Awareness global campaign, the first month long awareness campaign of its kind in the healthcare industry. November 1st is dedicated to all C. diff. Survivors worldwide.

According to the Centers for Disease Control and Prevention (CDC), Clostridium difficile infection (C. difficile) "has become the most common microbial cause of healthcare-associated infections in U.S. hospitals and costs up to $4.8 billion each year in excess health care costs for acute care facilities alone." Statistics provided by the CDC suggest that C. difficile cause nearly 500,000 infections in patients in the U.S. annually. In one study noted by the CDC, among infected patients, nearly 29,000 died within 30 days of being diagnosed, and more than half of those deaths (15,000) were directly attributable to a C. difficile infection.

"The C Diff Foundation members and volunteer patient advocates are dedicated in Raising C. diff. Awareness from villages to cities by sharing life-saving information," stated Nancy C. Caralla, C Diff Foundation's Foundress, and Executive Director.

November 4th attend the Tampa Bay Community "Raising C. diff. Awareness" event. Healthcare professionals deliver presentations beginning at 5:30 p.m. Spartan Manor, New Port Richey, FL. Tickets are $25, available online www.cdifffoundation.org or call 1-844-367-2343. We express our gratitude to our Corporate Sponsor: Xenex (www.xenex.com) and this activity is being supported by an independent patient advocacy grant from Merck & Co., Inc.

FREE 4 hour webinar on November 11, with 8 international healthcare professionals provided by the Global C.difficile Congress. "The goal is to broaden existing knowledge focused on C. difficile infection prevention, treatments, research, and environmental safety worldwide," says Caralla.

C. diff. community corporations around the globe are partnering to raise awareness and witness a shared goal in driving down newly diagnosed C. difficile infections and saving lives.

About the C Diff Foundation:
The C Diff Foundation, a 501(c)(3) non-profit, Founded in 2012 by Nancy C. Caralla, a nurse who was diagnosed and treated for Clostridium difficile (C. diff.) infections. Through her own journeys and the loss of her father to C. difficile infection involvement, Nancy recognized the need for greater awareness through education, about research being conducted by the government, industry, and academia and better advocacy on behalf of patients, healthcare professionals, and researchers worldwide working to address the public health threat posed by this devastating, life-threatening infection.

About The C Diff Foundation Foundress, Executive Director:
Nancy C. Caralla, hosts "C. diff. Spores and More" Global Broadcasting Network, and shares in a team focus on educating, and advocating for C. diff. infection prevention, treatments, and environmental safety -- and more -- worldwide.

Information: https://www.cdifffoundation.org/

Twitter: @cdiffFoundation #Nov4Cdiff

IMAGE: Send2Press.com/mediaboom/16-1020s2p-cdiff-300dpi.jpg

This release was issued through Send2Press®, a unit of Neotrope®. For more information, visit Send2Press Newswire at https://www.Send2Press.com

SOURCE C Diff Foundation